Journal alerts readers to “technical criticism” of CRISPR study – Retraction Watch (blog)
|
Journal alerts readers to “technical criticism” of CRISPR study
Retraction Watch (blog) A Nature journal has posted a editor’s note to a recent letter on potential unintended consequences of CRISPR gene editing, after an executive at a company trying to commercialize the technology said the paper should be retracted. The original article … |
|
Mayo Clinic Ventures funds new cancer-fighting cell, gene therapy
Post-Bulletin Vineti, a pioneering cell and gene therapy software and analytics company, announced Tuesday that it had completed its initial round of funding — raising $13.75 million — aimed at delivering “the first cloud-based software solution to improve patient … |
|
Intermountain works to advance cancer immunotherapy
St. George Daily Spectrum Immunotherapy is the treatment of disease with substances that stimulate the body’s immune response. Cancer immunotherapy, or immuno-oncology, uses the immune system to help fight cancer by augmenting specific parts of the body’s natural defenses. |
Genetic Literacy Project |
Stem cell therapy relying on patient’s own unhealthy heart may be dangerous
Genetic Literacy Project “We concluded that stem cells used in cardiac therapy should be drawn from healthy donors or be better genetically engineered for the patient,” said lead researcher Jonathan Leor of the university’s Sackler Faculty of Medicine and Sheba Medical Center. |
|
Sarepta Therapeutics and Genethon Announce a Gene Therapy Research Collaboration for the Treatment of …
Nasdaq “This partnership brings together our collective experience in Duchenne drug development and Genethon’s particular expertise in gene therapy for rare diseases. We look forward to working with Genethon given their knowledge, large infrastructure and … |